Abstract
The use of biologics in the treatment of back pain is gaining rapid popularity due to their potential ability to repair and restore homeostasis. Several autologous and allogenic products are now available, although clinical data supporting their use remain limited. In this chapter, we will discuss the clinical applications of commonly used biologics, with an emphasis on autologous PRP and autologous MSCs. We will focus on their use in the treatment of the most common sources of pain in the lumbar spine, i.e., the intervertebral disks (IVDs), the facet joints, and the sacroiliac (SI) joints.
The objective of this chapter is to provide a basic overview of the available literature, concept, and guidelines for the safe and effective use of biologic therapy in the lumbar spine, with a focus on axial skeleton pain, including intervertebral disks (IVDs), facet joints, and sacroiliac (SI) joints.
We present an initial review of available biologics, as well as the biomechanics of the axial spine, followed by a comprehensive review and analysis of all published clinical studies in the field of regenerative medicine that are relevant to the topics that were reviewed and analyzed.
The discovery of biologics has prompted their consideration for alleviating pain and improving function, as well as for potentially restoring the normal structure of the spine. Additional high-quality studies are needed for deeper insight into the long-term safety and efficacy of regenerative medicine modalities pertinent to the spine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Navani A, Manchikanti L, Albers S, et al. Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2019;22:S1–S74.
Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, Horst C, Li Z, Matyasz T, Reynolds A, Sadat N, Schneider MT, Murray CJL. Factors associated with increase in US health care spending, 1996–2013. JAMA. 2017;318:1668–78.
Conway PH. Editorial: factors associated with increased US health care spending. Implications for controlling health care costs. JAMA. 2017;318:1657–8.
Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar intradiscal platelet-rich plasma (PRP) injections: a prospective, double blind, randomized controlled. PM R. 2016;8(1):1–10.
Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016;40(6):1321–8.
Akeda K, Ohishi K, Masuda K, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial. Asian Spine J. 2017;11(3):380–9.
Levi D, Horn S, Tyszko S, et al. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med. 2016;17(6):1010–22.
Kirchner F, Anitua E. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors in patients with chronic low back pain. J Craniovertebr Junction Spine. 2016;7(4):250–6.
Navani A, Ambach M, Navani R, Wei J. Biologics for lumbar discogenic pain: 18-month follow up for safety and efficacy. Interv Pain Manag Rep. 2018;2(3):111–8.
Noriega DC, Adura F, Hernández-Ramajo R, MartÃn-Ferrero MA, Sánchez-Lite I, Toribio B, Alberca M, GarcÃa V, Moraleda JM, Sánchez A, Garcia-Sancho J. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;10:1945–51.
Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two-year follow-up. Int Orthop. 2016;40:135–40.
Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 joint spine section meeting. J Neurosurg Spine. 2013;18:85–95.
Orozco L, Soler R, Morera C, Alberca M, Sánchez A, GarcÃa-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92:822–8.
Kumar H, Ha DH, Lee EJ, Park JH, Shim JH, Ahn TK, Kim KT, Ropper AE, Sohn S, Kim CH, Thakor DK, Lee SH, Han IB. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther. 2017;8:262.
Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cell Mater. 2015;29:202–12.
Meisel HJ, Ganey T, Hutton WC, Libera J, Minkus Y, Alasevic O. Clinical experience in cell based therapeutics: intervention and outcome. Eur Spine J. 2006;15:S397annular-S405.
Beall DP, Davis T, DePalma MJ, Amirdelfan K, Yoon ES, Wilson GL, Bishop R, Tally WC, Gershon SL, Lorio MP, Meisel HJ, Langhorst M, Ganey T, Hunter CW. Viable disc tissue allograft supplementation; one- and two-level treatment of degenerated intervertebral discs in patients with chronic discogenic low back pain: one year results of the VAST randomized controlled trial. Pain Physician. 2021;24(6):465–77. PMID: 34554689.
Amirdelfan K, Bae H, McJunkin T, DePalma M, Kim K, Beckworth WJ, Ghiselli G, Bainbridge JS, Dryer R, Deer TR, Brown RD. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J. 2021;21(2):212–30. https://doi.org/10.1016/j.spinee.2020.10.004. Epub 2020 Oct 9. PMID: 33045417.
Wu T, Song HX, Dong Y, Li J. Cell-based therapies for lumbar discogenic low back pain: systematic review and single-arm meta-analysis. Spine (Phila Pa 1976). 2018;43:49–57.
Beall D, Wilson G, Bishop R, Tally W. VAST clinical trial: safely supplementing tissue lost to degenerative disc disease. Int J Spine Surg. 2020;14(2):239–53. https://doi.org/10.14444/7033.
Manchikanti L, Hirsch JA, Falco FJ, Boswell MV. Management of lumbar zygapophyseal (facet) joint pain. World J Orthop. 2016;7:315–37.
Teichtahl AJ, Wluka AE, Wijethilake P, et al. Wolff’s law in action: a mechanism for early knee osteoarthritis. Arthritis Res Ther. 2015;1:17207.
Wu J, Zhou J, Liu C, Zhang J, **ong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A prospective study comparing platelet-rich plasma and local anesthetic (LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint syndrome. Pain Pract. 2017;17:914–24.
Wu J, Du Z, Lv Y, Zhang J, **ong W, Wang R, Liu R, Zhang G, Liu Q. A new technique for the treatment of lumbar facet joint syndrome using intra-articular injection with autologous platelet rich plasma. Pain Physician. 2016;19:617–25.
Kirchner F, Anitua E. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors reduce pain in patients with chronic low back pain. J Craniovertebr Junction Spine. 2016;7:250–6.
Simopoulos TT, Manchikanti L, Gupta S, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2015;18:E713–56.
Nagamoto Y, Iwasaki M, Sakaura H, et al. Sacroiliac joint motion in patients with degenerative lumbar spine disorders. J Neurosurg Spine. 2015;23(2):209–16.
Ko GD, Mindra S, Lawson GE, et al. Case series of ultrasound-guided platelet- rich plasma injection for sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017;30(2):363–70.
Singla V, Batra YK, Bharti N, Goni VG, Marwaha N. Steroid vs. platelet-rich plasma in ultrasound-guided sacroiliac joint injection for chronic low back pain. Pain Pract. 2017;17:782–91.
Navani A, Gupta D. Role of intra-articular platelet-rich plasma in sacroiliac joint pain. Reg Anesth Pain Med. 2015;19:54–9.
Lin C-S, Lin G, Lue TF. Allogenic and xenogenetic transplantation of adipose- derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev. 2012;21(15):2770–8.
O’Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18(6):835–75.
Wang Y, Zhao S. Vascular biology of the placenta. San Rafael: Morgan and Claypool Life Sciences; 2010.
Rodolfa K, di Giorgio FP, Sullivan S. Defined reprogramming: a vehicle for changing the differentiated state. Differentiation. 2007;75(7):577–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Navani, A., Chrystal, J. (2023). Axial Spine and Sacroiliac Joint. In: Hunter, C.W., Davis, T.T., DePalma, M.J. (eds) Regenerative Medicine . Springer, Cham. https://doi.org/10.1007/978-3-030-75517-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-75517-1_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75516-4
Online ISBN: 978-3-030-75517-1
eBook Packages: MedicineMedicine (R0)